← FDA DRUG APPROVALS

FDA ANDA · ANDA210403

AMANTADINE HYDROCHLORIDE

Sponsor: JUBILANT GENERICS

APPLICATION
ANDA210403
TYPE
ANDA
ORIGINAL APPROVAL
2018-02-07
LATEST ACTION
2025-07-10
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

AMANTADINE HYDROCHLORIDEDiscontinued
AMANTADINE HYDROCHLORIDE 100MG · TABLET · ORAL

Approval history

2025-07-10Labeling · Supplement 11 · standardAP
2019-10-25Labeling · Supplement 1 · standardAP
2018-02-07UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →